Ling Wang1, Hui-Ping Li2, An-Nuo Liu2, De-Bin Wang3, Ya-Juan Yang2, Yan-Qin Duan4, Qing-Na Zhang5. 1. Department of Nursing, Wannan Medical College, Wuhu, China; School of Nursing, Anhui Medical University, Heifei, China. 2. School of Nursing, Anhui Medical University, Heifei, China. 3. School of Health Services Management, Anhui Medical University, Heifei, China. 4. People's Hospital of Huaibei City, Huaibei, China. 5. The First Affiliated Hospital of Anhui Medical University, Heifei, China.
Abstract
BACKGROUND: Lymphedema (LE) is recognized as a common complication after axillary lymph node dissection (ALND). Numerous studies have attempted to identify risk factors for LE. However, it is difficult to predict the probability of LE for an individual patient. The purpose of this study was to construct a scoring system for predicting the probability of LE after ALND for Chinese breast cancer patients. PATIENTS AND METHODS: 358 breast cancer patients were surveyed and followed for 12 months. LE was defined by circumferential measurement. Univariate and multivariate logistic regression analyses were used to screen risk factors of LE. Based on this, ß-coefficient of each risk factor was translated into a prognostic score and the scoring system was constructed. The area under the receiver operating characteristic curve (AUC) and calibration were calculated as an index for the predictive value of the scoring system. The model was internally validated using bootstrapping techniques. RESULTS: The incidence rate of LE was 31.84%. Variables associated with LE and their corresponding score in the scoring system were: the level of ALND (level I = 0, level II = 1, level III = 2), history of hypertension (yes = 1, no = 0), surgery on dominant arm (yes = 1, no = 0), radiotherapy (yes = 2, no = 0), and surgical infection/seroma/early edema (yes = 2, no = 0). The probability of LE was predicted according to the total risk scores. The system had good discrimination, with an AUC at 0.877. If a cut-off value of 3 was used, the sensitivity was 81.20% and the specificity was 80.90%. An individual whose total risk score was higher than 3 was recognized as being at risk for LE. On internal validation, the bootstrap-corrected predictive accuracy was 0.798. The model demonstrated excellent calibration in the development set and internal validation. CONCLUSIONS: Our scoring system could be a simple and easy tool for physicians to estimate the risk of LE.
BACKGROUND:Lymphedema (LE) is recognized as a common complication after axillary lymph node dissection (ALND). Numerous studies have attempted to identify risk factors for LE. However, it is difficult to predict the probability of LE for an individual patient. The purpose of this study was to construct a scoring system for predicting the probability of LE after ALND for Chinese breast cancerpatients. PATIENTS AND METHODS: 358 breast cancerpatients were surveyed and followed for 12 months. LE was defined by circumferential measurement. Univariate and multivariate logistic regression analyses were used to screen risk factors of LE. Based on this, ß-coefficient of each risk factor was translated into a prognostic score and the scoring system was constructed. The area under the receiver operating characteristic curve (AUC) and calibration were calculated as an index for the predictive value of the scoring system. The model was internally validated using bootstrapping techniques. RESULTS: The incidence rate of LE was 31.84%. Variables associated with LE and their corresponding score in the scoring system were: the level of ALND (level I = 0, level II = 1, level III = 2), history of hypertension (yes = 1, no = 0), surgery on dominant arm (yes = 1, no = 0), radiotherapy (yes = 2, no = 0), and surgical infection/seroma/early edema (yes = 2, no = 0). The probability of LE was predicted according to the total risk scores. The system had good discrimination, with an AUC at 0.877. If a cut-off value of 3 was used, the sensitivity was 81.20% and the specificity was 80.90%. An individual whose total risk score was higher than 3 was recognized as being at risk for LE. On internal validation, the bootstrap-corrected predictive accuracy was 0.798. The model demonstrated excellent calibration in the development set and internal validation. CONCLUSIONS: Our scoring system could be a simple and easy tool for physicians to estimate the risk of LE.
Entities:
Keywords:
Breast cancer; Lymphedema scoring system
Authors: Robert E Mansel; Lesley Fallowfield; Mark Kissin; Amit Goyal; Robert G Newcombe; J Michael Dixon; Constantinos Yiangou; Kieran Horgan; Nigel Bundred; Ian Monypenny; David England; Mark Sibbering; Tholkifl I Abdullah; Lester Barr; Utheshtra Chetty; Dudley H Sinnett; Anne Fleissig; Dayalan Clarke; Peter J Ell Journal: J Natl Cancer Inst Date: 2006-05-03 Impact factor: 13.506
Authors: Johan S Rietman; Pieter U Dijkstra; Jan H B Geertzen; Peter Baas; Jaap De Vries; Wil Dolsma; Johan W Groothoff; Willem H Eisma; Harald J Hoekstra Journal: Cancer Date: 2003-08-15 Impact factor: 6.860
Authors: Christian S Hinrichs; Nancy L Watroba; Hamed Rezaishiraz; William Giese; Thelma Hurd; Kathleen A Fassl; Stephen B Edge Journal: Ann Surg Oncol Date: 2004-06 Impact factor: 5.344